Literature DB >> 3120529

MR imaging of optic pathways in patients with neurofibromatosis.

E W Brown1, V M Riccardi, M Mawad, S Handel, A Goldman, R N Bryan.   

Abstract

Twenty-one patients with documented neurofibromatosis had MR examinations to evaluate possible intracranial disease. In five cases the indication was a known or suspected optic glioma. Two patients were examined because of a history of seizures; the rest were examined as part of a baseline evaluation. Eighteen patients showed evidence of signal hyperintensity on T2-weighted images. Lesions involved the optic nerves, optic chiasm, optic tracts, lateral geniculate body, optic radiations, basal ganglia, periventricular white matter, cerebellar white matter, and dentate nucleus of the cerebellum. Comparison between MR and concurrent CT scans showed MR to be superior in demonstrating the posterior extent of optic-pathway gliomas. In addition, MR showed focal areas of hyperintensity in the basal ganglia, internal capsule, cerebellum, and/or white matter that were not detected on CT. Although we found MR to be superior to CT in detecting intracranial tumors in patients with neurofibromatosis, and in evaluating the extensive involvement of known lesions, the full clinical implications of our findings remain to be determined.

Entities:  

Mesh:

Year:  1987        PMID: 3120529      PMCID: PMC8332345     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  12 in total

1.  Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis.

Authors:  L Kornreich; S Blaser; M Schwarz; A Shuper; T H Vishne; I J Cohen; R Faingold; S Michovitz; B Koplewitz; G Horev
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

2.  CT detection of basal ganglion lesions in neurofibromatosis type 1: correlation with MRI.

Authors:  F Menor; L Marti-Bonmatí
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

3.  MRI findings in children with neurofibromatosis type 1: a prospective study.

Authors:  S Van Es; K N North; K McHugh; M De Silva
Journal:  Pediatr Radiol       Date:  1996-07

4.  MRI and CT evaluation of brain in neurofibromatosis. Case report.

Authors:  A Carella; P D'Aprile; N Medicamento; E Alloro; F Federico; G Krajewska
Journal:  Ital J Neurol Sci       Date:  1989-12

Review 5.  An integrated approach to the treatment of chiasmatic-hypothalamic gliomas.

Authors:  M Garvey; R J Packer
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

Review 6.  Special issues in the management of gliomas in children with neurofibromatosis 1.

Authors:  I F Pollack; J J Mulvihill
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

7.  Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1.

Authors:  José Roberto Lopes Ferraz Filho; Marcos Pontes Munis; Antonio Soares Souza; Rafael Angelo Sanches; Eni Maria Goloni-Bertollo; Erika Cristina Pavarino-Bertelli
Journal:  Pediatr Radiol       Date:  2008-01-30

8.  Analysis of 20 primarily surgically treated chiasmatic/hypothalamic pilocytic astrocytomas.

Authors:  J M Valdueza; F Lohmann; O Dammann; C Hagel; B Eckert; N Freckmann
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

9.  Early diagnosis of optic glioma in children with neurofibromatosis type 1.

Authors:  L N Rossi; G Pastorino; G Scotti; M Gazocchi; M M Maninetti; C Zanolini; A Chiodi
Journal:  Childs Nerv Syst       Date:  1994-09       Impact factor: 1.475

10.  Neurofibromatosis type 1 and sporadic optic gliomas.

Authors:  S Singhal; J M Birch; B Kerr; L Lashford; D G R Evans
Journal:  Arch Dis Child       Date:  2002-07       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.